JohnKChanMD

Gynecologic Oncology

Associate Professor of Obstetrics & Gynecology, UCSF

Dr. Chan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California (Irvine)Residency, Obstetrics and Gynecology, 1995 - 1999
David Geffen School of Medicine at UCLAClass of 1995

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

PubMed

Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer.
Whitney S Graybill, Ignace Vergote, Bhavana Pothuri, Maarit Anttila, David M O'Malley
Journal of Comparative Effectiveness Research. 2025-01-01
1 citations
Real-world use of immune checkpoint inhibitors in advanced or recurrent endometrial cancer.
Sarah Huepenbecker, Larissa A Meyer, Miranda Craft, John K Chan, Christopher Craggs
International Journal of Gynecological Cancer. 2024-11-04
2 citations
Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy.
Christof Vulsteke, Setsuko K Chambers, Maria Jesús Rubio Pérez, John K Chan, Nicoline Raaschou-Jensen
European Journal of Cancer. 2024-09-01

Journal Articles

Impact of Adjuvant Treatment and Prognostic Factors in Stage I Uterine Leiomyosarcoma Patients Treated in Commission on Cancer®-Accredited Facilities
John K Chan, Yovanni Casablanca, Gynecologic Oncology

Lectures

Differences in survival between Caucasians and Asians.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018